Morgan Stanley says Korean beauty products will hit $4 billion in U.S. sales by 2026. That's this year. They're not forecasting the future. They're describing what's already happening while pretending it's analysis.
K-beauty went mainstream because Americans saw a ten-step skincare routine and thought "finally, something more complicated than my Robinhood portfolio." Sheet masks. Snail mucin. Essences that sound like they belong in a Tolkien novel. None of it matters for your technical analysis but all of it matters to the twenty-three year old who just discovered the Fibonacci retracement tool and thinks her pores are holding her back from being taken seriously as a day trader.
The growth thesis here is simple. Americans are bad at skincare. Koreans are good at it. We import their products. We overpay. We convince ourselves we look younger. This is the same psychological framework that makes retail traders believe they can time the market after watching three YouTube videos.
Morgan Stanley put a number on it because that's what Morgan Stanley does. They could have said "a lot" or "more than before" but then they couldn't charge clients for the report. $4 billion sounds precise. Sounds researched. Sounds like someone ran a DCF model on moisturizer.
The funniest part is not that Americans are spending billions on Korean face products. It's that someone at a bulge bracket bank spent weeks modeling the TAM for toner pads while the S&P did whatever the f*ck the S&P does regardless of how dewy anyone's complexion looks. Chart patterns don't care about your T-zone. Support and resistance levels remain unmoved by your essence routine.
But sure, let's all buy calls on beauty trends because some analyst decided hydrated skin is a secular growth story.
Photo by Felicia Buitenwerf on Unsplash
Leave a Comment